US 11,911,073 B2
Biosensor inserter apparatus and methods
Nicholas Erekovcanski, Butler, NJ (US); Eugene R. Prais, West Milford, NJ (US); Thomas A. J. Mayer, Jr., Glenmoore, PA (US); and Cameron M. Young, Tarrytown, NY (US)
Assigned to Ascensia Diabetes Care Holdings AG, Basel (CH)
Filed by Ascensia Diabetes Care Holdings AG, Basel (CH)
Filed on Feb. 8, 2023, as Appl. No. 18/166,155.
Application 18/166,155 is a continuation of application No. 16/984,125, filed on Aug. 3, 2020, granted, now 11,602,373.
Claims priority of provisional application 63/027,346, filed on May 19, 2020.
Claims priority of provisional application 62/889,444, filed on Aug. 20, 2019.
Prior Publication US 2023/0181218 A1, Jun. 15, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 17/34 (2006.01); A61B 5/145 (2006.01); A61B 5/00 (2006.01)
CPC A61B 17/3468 (2013.01) [A61B 5/14532 (2013.01); A61B 5/6847 (2013.01); A61B 17/3496 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A biosensor inserter, comprising:
a push member receiving a contact member therein, the contact member being translatable relative to the push member, the contact member configured to translate within the push member upon a force exerted on the push member;
a pivot member comprising a latch end and an injection device support end opposite of the latch end, the latch end arranged to engage the push member; and
an insertion device comprising a body portion and an insertion portion, the body portion including at least one leg arranged to engage a fork disposed at the injection device support end of the pivot member,
wherein the insertion device is drivable by the pivot member to insert a biosensor via the insertion portion.